Sponsors (28)
The bill expands federally funded preventive services and strengthens follow-up and monitoring—improving health outcomes for underserved women at scale—while requiring $250 million in federal spending and creating potential variability in access and additional administrative burdens.
Low-income women and uninsured individuals will gain access to expanded preventive services (e.g., blood pressure and cholesterol screening, health education) and stronger referral/follow-up requirements that increase the likelihood abnormal screening results lead to timely treatment.
Underserved populations will benefit from a federal appropriation of $250 million over five years to expand preventive services, which should reduce long-term healthcare costs from untreated conditions.
State governments, hospitals, and health systems will gain federally supported evaluation and surveillance capacity to monitor program performance and improve public health tracking.
Access to services depends on Secretary-specified eligibility rules and designee approvals, which could create variability in who receives services across states and yield unequal access for some women and low-income individuals.
Taxpayers bear the $250 million appropriation cost, which may pressure other federal priorities or require trade-offs in future budgets.
Grant recipients (state health agencies, hospitals, clinics) may face increased administrative and reporting burdens to meet referral, follow-up, and evaluation requirements.
Based on analysis of 2 sections of legislative text.
Authorizes CDC supplemental grants to expand preventive heart-health services for low-income women and funds $250M for FY2027–2031.
Introduced February 9, 2026 by Joyce Beatty · Last progress February 9, 2026
Authorizes the CDC Director to award supplemental grants to existing recipients of grants under the breast and cervical cancer screening program to add preventive heart-health services for low-income women. Funded activities may include blood pressure and cholesterol screening, health education, referrals and follow-up for treatment, and program evaluation, with $250 million authorized for fiscal years 2027–2031.